Free Trial
NASDAQ:RCEL

Avita Medical (RCEL) Stock Price, News & Analysis

Avita Medical logo
$5.63 +0.02 (+0.36%)
Closing price 07/9/2025 04:00 PM Eastern
Extended Trading
$5.62 0.00 (-0.09%)
As of 04:36 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Avita Medical Stock (NASDAQ:RCEL)

Key Stats

Today's Range
$5.56
$5.87
50-Day Range
$4.77
$9.50
52-Week Range
$4.71
$14.16
Volume
356,160 shs
Average Volume
189,391 shs
Market Capitalization
$148.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.50
Consensus Rating
Moderate Buy

Company Overview

Avita Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
17th Percentile Overall Score

RCEL MarketRank™: 

Avita Medical scored higher than 17% of companies evaluated by MarketBeat, and ranked 854th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Avita Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Avita Medical has only been the subject of 1 research reports in the past 90 days.

  • Read more about Avita Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Avita Medical are expected to grow in the coming year, from ($0.95) to ($0.04) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Avita Medical is -2.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Avita Medical is -2.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Avita Medical has a P/B Ratio of 33.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Avita Medical's valuation and earnings.
  • Percentage of Shares Shorted

    18.29% of the float of Avita Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Avita Medical has a short interest ratio ("days to cover") of 17, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Avita Medical has recently increased by 13.38%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Avita Medical does not currently pay a dividend.

  • Dividend Growth

    Avita Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    18.29% of the float of Avita Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Avita Medical has a short interest ratio ("days to cover") of 17, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Avita Medical has recently increased by 13.38%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    Only 1 people have searched for RCEL on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Avita Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.80% of the stock of Avita Medical is held by insiders.

  • Percentage Held by Institutions

    Only 27.66% of the stock of Avita Medical is held by institutions.

  • Read more about Avita Medical's insider trading history.
Receive RCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avita Medical and its competitors with MarketBeat's FREE daily newsletter.

RCEL Stock News Headlines

AVITA Medical, Inc. (RCEL) - Yahoo Finance
Trump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?
Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that you don't want to take with your retirement savings.
See More Headlines

RCEL Stock Analysis - Frequently Asked Questions

Avita Medical's stock was trading at $12.80 on January 1st, 2025. Since then, RCEL stock has decreased by 56.0% and is now trading at $5.63.

Avita Medical Inc. (NASDAQ:RCEL) issued its earnings results on Thursday, May, 8th. The company reported ($0.53) EPS for the quarter, missing analysts' consensus estimates of ($0.39) by $0.14. The company earned $18.51 million during the quarter, compared to analysts' expectations of $33.15 million. Avita Medical had a negative trailing twelve-month return on equity of 632.62% and a negative net margin of 79.61%.
Read the conference call transcript
.

Shares of RCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avita Medical investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD) and Tesla (TSLA).

Company Calendar

Last Earnings
5/08/2025
Today
7/09/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:RCEL
CIK
1762303
Fax
N/A
Employees
130
Year Founded
2008

Price Target and Rating

High Price Target
$21.00
Low Price Target
$12.00
Potential Upside/Downside
+193.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$61.85 million
Pretax Margin
-79.56%

Debt

Sales & Book Value

Annual Sales
$71.66 million
Price / Cash Flow
N/A
Book Value
$0.17 per share
Price / Book
33.12

Miscellaneous

Free Float
25,695,000
Market Cap
$148.83 million
Optionable
Optionable
Beta
1.52

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:RCEL) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners